AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 156 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,334,000 | +18.3% | 87,132 | +7.9% | 0.13% | +18.5% |
| Q1 2022 | $1,128,000 | +1609.1% | 80,750 | +100.9% | 0.11% | +1700.0% |
| Q4 2021 | $66,000 | -84.4% | 40,200 | -71.3% | 0.01% | -72.7% |
| Q2 2021 | $424,000 | +100.9% | 140,151 | +209.4% | 0.02% | +57.1% |
| Q1 2021 | $211,000 | +137.1% | 45,300 | +126.5% | 0.01% | +75.0% |
| Q4 2020 | $89,000 | +107.0% | 20,000 | +100.0% | 0.01% | +100.0% |
| Q4 2019 | $43,000 | -95.9% | 10,000 | -85.5% | 0.00% | -98.5% |
| Q3 2019 | $1,042,000 | – | 69,052 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |